SCHEMBL32669413

SCHEMBL32669413

COc1ccc2[nH]cc(CCN3CCCC3C)c2c1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.67
HTR1A P08908 7/20 0.62
HTR1B P28222 3/20 0.62
HRH3 Q9Y5N1 6/20 0.61
TSHR P16473 2/20 0.59
KDM4E B2RXH2 1/20 0.59
CYP2D6 P10635 1/20 0.55
CYP1A2 P05177 1/20 0.55
MAPT P10636 1/20 0.55
NFKB1 P19838 1/20 0.55
HTR1D P28221 1/20 0.55
HTR2C P28335 1/20 0.55
HTR7 P34969 1/20 0.55
HTR6 P50406 1/20 0.55
HTR4 Q13639 1/20 0.55
TRPM8 Q7Z2W7 1/20 0.55
BLM P54132 1/20 0.54
PMP22 Q01453 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26508872 0.93 HTR2A (0.67) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL27206364 0.86 HTR1A (0.65) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL27191685 0.86 HTR1A (0.65) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL26508885 0.82 HTR2A (0.64) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL26508878 0.81 HTR2A (0.63) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL26508880 0.81 HTR2A (0.66) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL11519929 0.81 HTR2A (0.65) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL25249411 0.81 HTR2A (1.00) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL29633130 0.81 HTR2A (0.97) HTR2AHTR1AHTR1BTSHRCYP2D6
SCHEMBL24723815 0.81 HTR2A (0.97) HTR2AHTR1AHTR1BTSHRCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034119-A1 5-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034119-A1 5-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS HTR4, OPRM1, HTR7 HTR2A 12/4885HTR1A 4/4885HTR1B 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.